Tuberous sclerosis complex, implication from a rare genetic disease to common cancer treatment

K Inoki, KL Guan - Human molecular genetics, 2009 - academic.oup.com
Human molecular genetics, 2009academic.oup.com
Tuberous sclerosis complex (TSC) is a relatively rare autosomal dominant disorder
characterized by widespread benign tumor formation in a variety of organs. Mutations in
either TSC1 or TSC2 tumor suppressor gene are responsible for TSC. The gene products of
TSC1 and TSC2, also known as hamartin and tuberin, respectively, form a physical and
functional complex and inhibit the mammalian target of rapamycin complex 1 (mTORC1)
signaling. The mTORC1 pathway is an evolutionarily conserved growth promoting pathway …
Tuberous sclerosis complex (TSC) is a relatively rare autosomal dominant disorder characterized by widespread benign tumor formation in a variety of organs. Mutations in either TSC1 or TSC2 tumor suppressor gene are responsible for TSC. The gene products of TSC1 and TSC2, also known as hamartin and tuberin, respectively, form a physical and functional complex and inhibit the mammalian target of rapamycin complex 1 (mTORC1) signaling. The mTORC1 pathway is an evolutionarily conserved growth promoting pathway. mTORC1 plays an essential role in a wide array of cellular processes including translation, transcription, trafficking and autophagy. In this review, we will discuss recent progresses in the TSC-mTOR field and their physiological functions and alterations of this pathway in pathophysiology.
Oxford University Press